Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice.


Journal

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
ISSN: 1414-431X
Titre abrégé: Braz J Med Biol Res
Pays: Brazil
ID NLM: 8112917

Informations de publication

Date de publication:
2020
Historique:
received: 05 05 2020
accepted: 08 08 2020
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 13 11 2020
Statut: epublish

Résumé

Sensory neuropathy is a dose-limiting side effect of oxaliplatin-based cancer treatment. This study investigated the antinociceptive effect of amifostine and its potential neuroprotective mechanisms on the oxaliplatin-related peripheral sensory neuropathy in mice. Oxaliplatin (1 mg/kg) was injected intravenously in Swiss albino male mice twice a week (total of nine injections), while amifostine (1, 5, 25, 50, and 100 mg/kg) was administered subcutaneously 30 min before oxaliplatin. Mechanical and thermal nociceptive tests were performed once a week for 49 days. Additionally, c-Fos, nitrotyrosine, and activating transcription factor 3 (ATF3) immunoexpressions were assessed in the dorsal root ganglia. In all doses, amifostine prevented the development of mechanical hyperalgesia and thermal allodynia induced by oxaliplatin (P<0.05). Amifostine at the dose of 25 mg/kg provided the best protection (P<0.05). Moreover, amifostine protected against neuronal hyperactivation, nitrosative stress, and neuronal damage in the dorsal root ganglia, detected by the reduced expression of c-Fos, nitrotyrosine, and ATF3 (P<0.05 vs the oxaliplatin-treated group). In conclusion, amifostine reduced the nociception induced by oxaliplatin in mice, suggesting the possible use of amifostine for the management of oxaliplatin-induced peripheral sensory neuropathy.

Identifiants

pubmed: 32965323
pii: S0100-879X2020001100601
doi: 10.1590/1414-431X202010263
pmc: PMC7510240
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Oxaliplatin 04ZR38536J
Amifostine M487QF2F4V

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e10263

Références

J Pineal Res. 2017 Apr;62(3):
pubmed: 28118492
J Neurosci. 2007 Jul 25;27(30):7911-20
pubmed: 17652582
Mol Cell Neurosci. 2000 Feb;15(2):170-82
pubmed: 10673325
Toxicology. 2012 Jan 27;291(1-3):1-9
pubmed: 22079234
Oncologist. 2015 Apr;20(4):411-32
pubmed: 25765877
Gynecol Oncol. 2005 Apr;97(1):60-7
pubmed: 15790438
Pain. 1978 Feb;4(3):231-42
pubmed: 634623
Mol Pain. 2011 Jan 20;7:8
pubmed: 21247499
Anticancer Res. 2014 Jan;34(1):517-23
pubmed: 24403510
Drug Des Devel Ther. 2017 Aug 01;11:2251-2263
pubmed: 28814833
Lancet Neurol. 2010 Aug;9(8):807-19
pubmed: 20650402
J Pain. 2012 Mar;13(3):276-84
pubmed: 22325298
Prog Brain Res. 1995;104:299-321
pubmed: 8552775
Int J Radiat Biol. 2014 Jul;90(7):594-604
pubmed: 24597748
Naunyn Schmiedebergs Arch Pharmacol. 2018 Sep;391(9):915-931
pubmed: 29860655
J Clin Oncol. 2004 Jan 1;22(1):23-30
pubmed: 14665611
Cochrane Database Syst Rev. 2014 Mar 31;(3):CD005228
pubmed: 24687190
Cancer Chemother Pharmacol. 2007 Jan;59(1):71-7
pubmed: 16708234
J BUON. 2011 Jan-Mar;16(1):154-9
pubmed: 21674868
Am J Health Syst Pharm. 2014 Jan 1;71(1):19-25
pubmed: 24352178
Clin Adv Hematol Oncol. 2003 Jul;1(7):404-5
pubmed: 16258421
Mol Pain. 2013 Oct 23;9:53
pubmed: 24152430
J Pain. 2008 May;9(5):463-72
pubmed: 18359667
Mol Cancer Ther. 2009 Jan;8(1):10-6
pubmed: 19139108
Ai Zheng. 2008 Oct;27(10):1117-20
pubmed: 18851795
Anesthesiology. 2014 Feb;120(2):459-73
pubmed: 24064792
Naunyn Schmiedebergs Arch Pharmacol. 2014 Sep;387(9):837-48
pubmed: 24908156
Braz J Med Biol Res. 2004 Mar;37(3):401-7
pubmed: 15060710
Cancer. 2007 Aug 1;110(3):670-7
pubmed: 17559146
PLoS One. 2015 Jun 03;10(6):e0128080
pubmed: 26039098
Indian J Pharmacol. 2010 Feb;42(1):17-20
pubmed: 20606831
Anticancer Drugs. 2002 Mar;13(3):181-209
pubmed: 11984063
Toxicol Appl Pharmacol. 2018 Feb 1;340:77-84
pubmed: 29307816
Int J Mol Sci. 2013 Dec 16;14(12):24438-75
pubmed: 24351827
J Neuroendocrinol. 2008 Jun;20(6):665-72
pubmed: 18601687
Braz J Med Biol Res. 2019 Feb 25;52(3):e8251
pubmed: 30810625
Brain. 2009 Oct;132(Pt 10):2712-23
pubmed: 19745023
Brain Res Bull. 1998;45(1):1-8
pubmed: 9434195
Crit Rev Oncol Hematol. 2012 Apr;82(1):51-77
pubmed: 21908200

Auteurs

A F Pereira (AF)

Departamento de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

J A Lino (JA)

Departamento de Medicina Clínica, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

B W F Alves (BWF)

Departamento de Morfologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

M R P Lisboa (MRP)

Departamento de Morfologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

R B Pontes (RB)

Departamento de Fisioterapia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

C A V G Leite (CAVG)

Departamento de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

R B Nogueira (RB)

Departamento de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

R C P Lima-Júnior (RCP)

Departamento de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

M L Vale (ML)

Departamento de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.
Departamento de Morfologia, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH